Dr. Anurag Das

Dr. Anurag Das
Dr. Das grew up in Brooklyn and then Long Island. Dr. Das served on active duty as a Major and Chief of Urology at USAF Hospital Kirtland in Albuquerque NM. He then established a busy research and clinical program in BPH, and voiding dysfunction at AMC Hospital and Albany Medical College, where he was an Associate Professor of Surgery/Urology. He then moved to become Director of the Center for Neuro-urology and Continence at Beth Israel Deaconess Medical Center and Harvard Medical School. After 18 years in Boston, he took his current position as Chief of Urology at SIUH. Urologic expertise includes BPH, Neuro-urology (urologic problems due to neurologic disease such as MS, Parkinson s disease etc), male and female incontinence, urethral strictures and complex urodynamics. Awards and Recognition: James C. Kimbrough Memorial Award for Urologic Research Montague L. Boyd Essay Contest- First Prize The Air Force Commendation Medal Boston Magazine Top Doctors 2008-2015, 2017-2021 New York Magazine Top Doctors 2022 Castle-Connolly Best Doctors in America 2008-2022 Panel Member: National AUA guideline on the diagnosis and treatment of non-neurogenic overactive bladder Panel member: National AUA Guideline on Management of Benign prostatic hyperplasia/ lower urinary tract symptoms Dr. Das has published over 50 scientific articles and book chapters and given presentations at numerous national and international urology meetings primarily on topics related to BPH, incontinence, voiding dysfunction, and sacral neuro-modulation.

Languages Spoken:

English, Hindi

Medical School:

Northwestern University Medical School


Duke University Medical Center


Duke University Medical Center


Northwestern University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only